Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02UNP
|
|||
| Former ID |
DIB011105
|
|||
| Drug Name |
IMA-901
|
|||
| Synonyms |
TUMAP vaccine (RCC), immatics; Tumor-associoated peptide vaccine (renal cell carcinoma), immatics
Click to Show/Hide
|
|||
| Indication | Renal cell carcinoma [ICD-11: 2C90; ICD-10: C64] | Phase 3 | [1] | |
| Company |
Immatics biotechnologies GmbH
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01265901) IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.